(1) TB-500 is a synthetic peptide identical to the 43 amino acid structure of the endogenous thymosin beta-4, studied for its involvement in cellular migration, cytoskeletal organization, and inflammatory signaling
This includes a phase 3 trial assessing the long-term efficacy and safety of this intervention, which is currently recruiting participants with completion expected in June 2025 [138], as well as a phase 4 trial assessing the role and mechanism of Bifidobacterium triple viable capsules, with expected completion in December 2023 [139]
Intended strictly for laboratory, in-vitro, and investigational research applications only
Improving Neural Plasticity Synaptic plasticity is the foundation of our ability to learn and remember.7 When we learn something new, the connections between the neurons involved in the process become stronger or new connections are formed.8 Activation of the TrkB receptor by DIHEXA may enhance these processes, facilitating the formation and consolidation of memory traces